Expert Review of Respiratory Medicine

Papers
(The H4-Index of Expert Review of Respiratory Medicine is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
How can we improve our use of allergen immunotherapy as a treatment option for asthma and severe asthma?101
Is COVID-19 masking the ongoing youth vaping crisis?60
Redox signaling and antioxidant therapies in acute respiratory distress syndrome: a systematic review and meta-analysis45
Moderate sedation with dexmedetomidine–remifentanil is safer than deep sedation with propofol–remifentanil for endobronchial ultrasound while providing comparable quality: a randomized double-blind tr32
A review of the efficacy and safety of fluticasone propionate/formoterol fixed-dose combination29
Relationship between patient functionality impairment and caregiver burden: is there a cut off point for the severe COPD patient?26
Multidisciplinary bronchopulmonary dysplasia care26
Do all patients with cancer thrombosis have the same risk of bleeding and recurrence? Particularities of lung cancer25
The effects of physical activity tele-counseling intervention on physical activity, functional performance, and quality of life in post-COVID-19 conditions: a randomized controlled trial25
Evaluation of exacerbation severity in patients with COPD exacerbations according to the GOLD 2023 report24
Drug-induced interstitial lung disease: a narrative review of a clinical conundrum24
Developments in smoking cessation interventions for patients with chronic obstructive pulmonary disease in the past 5 years: a scoping review22
What is personalized lung poromechanical modeling and how can it improve the understanding and management of fibrotic interstitial lung diseases?22
Intermittent abdominal pressure ventilation management in neuromuscular diseases: a Delphi panel Consensus20
Adherence to inhaled antibiotics in people with cystic fibrosis: insights from a virtual patient advisory board19
Sleep apnea is associated with the increase of certain genera of Ruminococcaceae and Lachnospiraceae in the gut microbiome of hypertensive patients18
The potential of volatile organic compound analysis for pathogen detection and disease monitoring in patients with cystic fibrosis18
Assessing accuracy of testing and diagnosis in cystic fibrosis18
First-line immunotherapy in non-small cell lung cancer: how to select and where to go18
0.10496520996094